# FDA Inspection 1242852 - Chinese Peptide Company - June 14, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/chinese-peptide-company/fd26dc53-e616-48c7-88cb-ceca57bbbe7c/
Source feed: FDA_Inspections

> FDA Inspection 1242852 for Chinese Peptide Company on June 14, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242852
- Company Name: Chinese Peptide Company
- Inspection Date: 2024-06-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 967430 - 2016-03-17](https://www.globalkeysolutions.net/api/records/fda_inspections/chinese-peptide-company/1543f4bc-c04a-453f-bcc6-c037c8540263/)
- [FDA Inspection 908354 - 2014-11-14](https://www.globalkeysolutions.net/api/records/fda_inspections/chinese-peptide-company/4b9de5c5-c370-4f89-8941-8be2d06a7e24/)
- [FDA Inspection 774762 - 2012-02-16](https://www.globalkeysolutions.net/api/records/fda_inspections/chinese-peptide-company/0f543af3-f995-4f6b-b5cb-1d41df7586ab/)

Company: https://www.globalkeysolutions.net/companies/chinese-peptide-company/ba8c6a32-f679-405b-bb0a-e82713b7cb62

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c